PQE Group is excited to announce the opening of its newest office in Montreal, Quebec, Canada, marking a significant expansion for the company. The expansion aims to provide enhanced services to both existing and potential clients across various regions in Canada. The Greater Montreal area, located along North America's east coast, is renowned for its vibrant life sciences community, featuring prestigious universities, leading hospitals, and innovative life sciences companies. Notably, Quebec serves as a hub for the development and acceleration of artificial intelligence (AI), reflecting its forward-thinking approach to shaping the future. Canada's expertise in AI, characterized by its high-quality research, skilled workforce, and contributions to AI innovation on a global scale, has been a key source of inspiration for PQE Group.
Recognizing the dynamic environment of Montreal, PQE Group saw this expansion as a crucial step in its global growth strategy. Montreal joins PQE Group's list of North American office locations, which includes San Diego, CA; Rockville, MD; Boston, MA; Raleigh, NC; Buffalo, NY; and Chicago, IL. Additionally, PQE Group maintains a presence in South and Latin America, Asia, Australia, and Europe, with its roots tracing back 25 years to its establishment in Tuscany, Italy.
The primary objective of PQE's new Montreal office is to leverage the company's global resources to support the continued growth and innovation of life science businesses based in Montreal and other parts of Canada. PQE Group already collaborates with companies in Ontario through its U.S. operations, and the proximity of the Montreal office to Ontario, which shares a border with Quebec, will further enhance these capabilities. The company also plans to focus on providing support to medical device and startup companies. PQE Group is currently engaged with life sciences organizations in Canada, and the establishment of a local office is expected to strengthen these partnerships.
The core mission of the new Montreal office is to drive innovation in the Canadian life sciences sector, aligning with PQE's commitment to fostering innovation across borders. To learn more about PQE and meet the PQE team, attendees can visit Exhibit Booth #34 at the PDA FDA Joint Regulatory Conference in Washington, DC, from September 18-20, as well as the Whiskey A Go-Go networking event on September 19.
PQE Group, Inc. is a renowned technology solutions provider with ISO 9001 certification, specializing in serving the pharmaceutical and medical device industries on a global scale. Established in 1998, PQE is recognized as a women-owned Contract Quality Organization and Complete Quality Solution provider, offering expertise in GCP, GLP, GMP, and GDP in the Life Sciences. The company's areas of specialization include Regulatory Affairs and Strategy, Quality Compliance, Third-Party Audits, Data Integrity Assurance, Digital Governance, Commissioning, Qualification and Engineering, and Laboratory Excellence. PQE Group emphasizes Corporate Social Responsibility (CSR) on its website and has successfully completed over 15,000 projects.
PQE Group is dedicated to delivering value to its clients by leveraging its multidisciplinary teams and knowledge to help clients achieve and maintain compliance with the latest regulations. The company's mission is to contribute to the creation of safe and efficacious medical device and pharmaceutical products for patients worldwide. PQE employs over 2,000 professional Subject Matter Experts and serves more than 1,400 medical device and pharmaceutical clients across 40+ office locations worldwide. PQE Group, Inc. is committed to providing turnkey quality solutions with a focus on cost-effectiveness and efficiency. The company has a proven track record of managing projects of varying scales, from large multi-site endeavors to smaller projects with pharmaceutical, biotech, and medical device clients, including startups. PQE Group adopts a "Glocal" approach, combining global expertise with local support to achieve global success.